Spironolactone Plus Minoxidil for Premenopausal Women: 2025 RCT Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in PMC (open access), 2025
Spironolactone Plus Minoxidil for Premenopausal Women
Study conclusion
Randomised controlled pilot trial in 48 premenopausal women found that adding spironolactone 100mg to topical minoxidil 3% produced synergistic improvements in hair loss compared to minoxidil alone. Irregular menstruation occurred in about one third of participants taking spironolactone.
Strength of evidence
This was a randomised controlled pilot trial in 48 participants. The score reflects a reasonable design for a pilot study but limited sample size and it being the first adequately controlled trial of this combination in premenopausal women specifically.
Who it applies to
Who was studied
48 premenopausal women with female pattern hair loss. Randomised to spironolactone 100mg plus topical minoxidil 3% vs topical minoxidil 3% alone.
Who was NOT studied
Men. Postmenopausal women. Women with other types of hair loss.
What to look for when shopping
Spironolactone is prescription-only and used off-label for hair loss. It is not FDA-approved for hair loss. Irregular menstruation is a common side effect requiring monitoring.
What research cannot help you decide
Whether the combination is better than spironolactone alone (not all three arms were included). Long-term effects beyond the trial period.
Key findings
- Adding spironolactone 100mg to topical minoxidil 3% produced synergistic hair loss improvement vs minoxidil alone
- Irregular menstruation occurred in approximately one third of participants in the spironolactone arm
- Spironolactone is not FDA-approved for hair loss
- This was a pilot trial — a larger confirmatory study is needed
What they did
Researchers randomised 48 premenopausal women with female pattern hair loss to spironolactone 100mg daily plus topical minoxidil 3%, or topical minoxidil 3% alone. Hair density and other hair parameters were measured at baseline and follow-up. Adverse events including menstrual irregularities were recorded.
What they found
| Comparison | Result | Significant? |
|---|---|---|
| Spironolactone + minoxidil vs minoxidil alone — hair improvement | Synergistic improvement with combination | Yes |
| Spironolactone — irregular menstruation | Occurred in approximately 1 in 3 participants | No |
What this study does not show
- 1.Whether the combination outperforms spironolactone alone.
- 2.Whether the combination is effective in postmenopausal women.
- 3.Long-term effects and safety beyond the trial period.
Limitations
- 1.Pilot trial with only 48 participants
- 2.Only premenopausal women studied
- 3.No spironolactone-alone arm — cannot determine contribution of spironolactone independently
- 4.Spironolactone is not FDA-approved for hair loss
Who funded it
No funding source declared. No conflicts of interest reported.
Used in these articles
Links added as fact-checks and articles citing this study are published.